Pharmacokinetics of ethanol: a review

Alcoholism, Clinical and Experimental Research
P K Wilkinson

Abstract

The pharmacokinetics of ethanol in man are reviewed from a historical perspective from the earliest attempts at kinetic analysis of urinary data in 1899 to the present nonlinear analysis of blood alcohol concentration (BAC) and time data. Review of the various kinetic theories that have been utilized to describe the kinetics of alcohol metabolism is provided. Extensive review is made of recent investigations supporting the application of Michaelis-Menten enzyme kinetics to describe alcohol metabolism. Results of direct, nonlinear least-squares computer fitting of BAC following intravenous and oral feeding of alcohol both in the fasting and fed states are presented with appropriate theory. The kinetics of the oral absorption of alcohol and the relationship among stomach emptying rate, the apparent absorption rate, and the area under the BAC-time curve are discussed and data presented. The kinetics of multiple Michaelis-Menten pathways are discussed with application to the (potential) contributions of the MEOS and/or ADH systems to the observed BAC curve and resultant kinetic parameters. Several methods of obtaining pharmacokinetic (Michaelis-Menten) parameters from BAC curves and their interpretation and usage in comparative stu...Continue Reading

References

Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·T K LiB L Vallee
Jan 10, 1977·Biochemical and Biophysical Research Communications·W F Borson, T K Li
Feb 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·P K WilkinsonJ G Wagner
Jun 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·P K WilkinsonJ G Wagner
Sep 1, 1976·Journal of Studies on Alcohol·A J SedmanJ G Wagner
Aug 1, 1975·British Journal of Clinical Pharmacology·D C Brown, J G Collier
Jan 1, 1976·Journal of Pharmaceutical Sciences·J G WagnerD J Weidler
Feb 1, 1976·Clinical Pharmacology and Therapeutics·P K WilkinsonJ G Wagner
Feb 1, 1972·European Journal of Biochemistry·R G ThurmanR Scholz
Nov 1, 1972·The Journal of Pharmacy and Pharmacology·G P MouldT B Binns
Apr 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·A J Sedman, J G Wagner
Jan 1, 1972·Clinical Pharmacology and Therapeutics·E M SellersH Kalant
Mar 1, 1974·Clinical Pharmacology and Therapeutics·M A EvansR B Forney
Apr 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·J G Wagner
Feb 1, 1972·American Journal of Obstetrics and Gynecology·J Idänpään-HeikkiläM Koivisto
Mar 1, 1971·Clinical Pharmacology and Therapeutics·E S VesellG T Passananti
Jan 1, 1958·Acta Pharmacologica Et Toxicologica·F LUNDQUIST, H WOLTHERS
May 14, 1940·The Journal of Physiology·M G Eggleton
May 14, 1940·The Journal of Physiology·M G Eggleton
Mar 13, 1926·British Medical Journal·H W Southgate, G Carter

❮ Previous
Next ❯

Citations

Jan 1, 1985·Psychopharmacology·C L Melchior, B Tabakoff
May 1, 1984·Bulletin of Environmental Contamination and Toxicology·K G RömerK J Freundt
Nov 1, 1988·Biochemical Pharmacology·V A da Silva, A E McLean
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·K E McMartin, T D Collins
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·P B SutkerC L Randall
Apr 1, 1986·Pharmacology, Biochemistry, and Behavior·C L Melchior, B Tabakoff
Mar 1, 1986·Pharmacology, Biochemistry, and Behavior·T F KalhornJ T Slattery
Jan 1, 1990·Pharmacology & Therapeutics·D P Agarwal, H W Goedde
May 1, 1983·Forensic Science International : Synergy·R BrunoG Jullien
May 1, 1987·Alcohol·E Romm, A C Collins
Sep 1, 1995·Journal of Clinical Forensic Medicine·D W Rockerbie, R A Rockerbie
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·M A Linseman, A D Lê
Jun 6, 2000·Advanced Drug Delivery Reviews·D D ShenK E Thummel
May 7, 2003·Drug and Alcohol Dependence·Allison Dorlen Pastor, Suzette M Evans
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·V P Dole, R T Gentry
Dec 1, 1996·Alcoholism, Clinical and Experimental Research·K DohmenC S Lieber
Jun 17, 1999·Alcoholism, Clinical and Experimental Research·M L KaltenbachL Zbierski
Apr 1, 1983·Journal of Clinical Pathology·V Marks
Mar 9, 2010·PloS One·Thierry LefèvreFrédéric Thomas
Jun 10, 2003·Clinical Pharmacokinetics·Jack Lotsof
May 1, 1988·Medical Toxicology and Adverse Drug Experience·B AdinoffM Linnoila
Jul 1, 1987·American Journal of Obstetrics and Gynecology·J F BrienJ Patrick
Jul 1, 1985·American Journal of Obstetrics and Gynecology·J F BrienJ Patrick
Jan 17, 2013·Alcohol·Gudrun HøisethJørg Mørland
Mar 23, 2010·Forensic Science International : Synergy·Alan Wayne Jones
Apr 28, 2009·Forensic Science International : Synergy·Alan Wayne Jones, Anita Holmgren
Mar 1, 1986·Journal - Forensic Science Society·L Campbell, H K Wilson
Mar 1, 1987·Drug and Alcohol Dependence·A W Chan
Dec 1, 1992·Forensic Science International : Synergy·R G Gullberg, A J McElroy
Jan 1, 1982·Alcoholism, Clinical and Experimental Research·J C CrabbeH Rigter
Jan 1, 1983·Alcoholism, Clinical and Experimental Research·H K Hahn, R E Burch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.